Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.

Tran D, Beeler JS, Liu J, Wiley B, Chan ICC, Xin Z, Kramer MH, Batchi-Bouyou AL, Zong X, Walter MJ, Petrone GEM, Chlamydas S, Ferraro F, Oh ST, Link DC, Busby B, Cao Y, Bolton KL

Open source

DOI: 10.1158/1078-0432.ccr-23-3468
Published: 2024 Aug 1
Container: Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-23-3468,
  title = {Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.},
  author = {Tran D and Beeler JS and Liu J and Wiley B and Chan ICC and Xin Z and Kramer MH and Batchi-Bouyou AL and Zong X and Walter MJ and Petrone GEM and Chlamydas S and Ferraro F and Oh ST and Link DC and Busby B and Cao Y and Bolton KL},
  year = {2024},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-23-3468},
  url = {https://doi.org/10.1158/1078-0432.ccr-23-3468}
}

RIS

TY  - JOUR
TI  - Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.
AU  - Tran D
AU  - Beeler JS
AU  - Liu J
AU  - Wiley B
AU  - Chan ICC
AU  - Xin Z
AU  - Kramer MH
AU  - Batchi-Bouyou AL
AU  - Zong X
AU  - Walter MJ
AU  - Petrone GEM
AU  - Chlamydas S
AU  - Ferraro F
AU  - Oh ST
AU  - Link DC
AU  - Busby B
AU  - Cao Y
AU  - Bolton KL
PY  - 2024
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-23-3468
UR  - https://doi.org/10.1158/1078-0432.ccr-23-3468
ER  -

APA

D, T., JS, B., J, L., B, W., ICC, C., Z, X., MH, K., AL, B., X, Z., MJ, W., GEM, P., S, C., F, F., ST, O., DC, L., B, B., Y, C., & KL, B. (2024). Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-23-3468

Source records

pubmed · retrieved 2026-09-26T14:18:52.035Z